https://www.sigmaaldrich.com/US/en/product/sial/phr3472
Azacitidine Related Compound B certified reference material, pharmaceutical secondary standard; CAS Number: 6974-32-9; Synonyms:...
secondary standardazacitidinerelatedcompoundb
https://www.cincinnatichildrens.org/service/c/clinical-trials/studies/RAVAML-011325
This is a research study to find out if adding a new study drug called revumenib to commonly used chemotherapy drugs is safe and if they have beneficial...
studyrevumenibazacitidinevenetoclaxpediatric
https://www.medicines.org.uk/emc/product/11884/pil
Azacitidine Tillomed 25 mg/mL powder for suspension for injection - Patient Information Leaflet (PIL) by Tillomed Laboratories Ltd
azacitidinemgmlpowdersuspension
https://www.mdanderson.org/patients-family/diagnosis-treatment/clinical-trials/clinical-trials-index/clinical-trials-detail.ID2019-0353.html
This phase II trial studies how well venetoclax and azacitidine work for the treatment of acute myeloid leukemia after stem cell transplantation. Venetoclax...
phase ii studyvenetoclaxcombinationazacitidine
https://www.medicines.org.uk/emc/product/15363/smpc/print
Azacitidine 25 mg/ml powder for suspension for injection - Summary of Product Characteristics (SmPC) by Thornton & Ross Ltd - print friendly
azacitidinemgmlpowdersuspension
https://www.hmpgloballearningnetwork.com/site/onc/quiz/chidamide-plus-azacitidine-maintenance-therapy-aml
True or false: Following allogeneic hematopoietic stem cell transplantation, dual epigenetic maintenance therapy with chidamide and azacitidine demonstrated...
acute myeloid leukemiamaintenance therapychidamideplusazacitidine
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-ivosidenib-combination-azacitidine-newly-diagnosed-acute-myeloid-leukemia
FDA approves ivosidenib in combination with azacitidine for newly diagnosed acute myeloid leukemia
newly diagnosedfdaivosidenibcombinationazacitidine